HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taku Amano Selected Research

S 312

7/2004Antiepileptic effects of single and repeated oral administrations of S-312-d, a novel calcium channel antagonist, on tonic convulsions in spontaneously epileptic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taku Amano Research Topics

Disease

4Seizures (Absence Seizure)
01/2018 - 09/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 02/2009
3Epilepsy (Aura)
01/2013 - 08/2002
3Tremor (Tremors)
07/2004 - 08/2002
2Hyperalgesia
09/2020 - 03/2007
2Neuroblastoma
11/2017 - 01/2017
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2017 - 09/2014
2Pain (Aches)
01/2017 - 01/2008
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
02/2009 - 08/2005
1Cardiotoxicity
10/2021
1Neuralgia (Stump Neuralgia)
09/2020
1Neoplasms (Cancer)
11/2017
1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Glioma (Gliomas)
01/2016
1Dementia (Dementias)
09/2014
1Mitochondrial Diseases (Mitochondrial Disease)
01/2013
1Bipolar Disorder (Manic Depressive Psychosis)
01/2013
1Schizophrenia (Dementia Praecox)
11/2012
1Insulin Resistance
11/2012
1Lipidoses
11/2012
1Weight Gain
11/2012
1Hallucinations (Hallucination)
12/2008
1Catalepsy
12/2008
1Vomiting
12/2008
1Hydrocephalus (Hydrocephaly)
08/2007
1Chronic Pain
03/2007
1Hypersensitivity (Allergy)
08/2003
1AIDS-Related Complex (ARC)
02/2002

Drug/Important Bio-Agent (IBA)

2EscitalopramFDA Link
10/2021 - 01/2018
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2021 - 01/2018
2Yi-Gan SanIBA
01/2017 - 09/2014
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2013 - 07/2004
2Opioid Analgesics (Opioids)IBA
12/2008 - 01/2008
2aspartoacylaseIBA
07/2004 - 08/2002
1CitalopramFDA LinkGeneric
10/2021
1neolineIBA
09/2020
1Streptozocin (Streptozotocin)FDA Link
09/2020
1NAV1.7 Voltage-Gated Sodium ChannelIBA
09/2020
1gosha-jinki-ganIBA
09/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2020
1liquiritinIBA
11/2017
1Neuroprotective AgentsIBA
11/2017
1neoisoliquiritinIBA
11/2017
1Glycyrrhizic Acid (Glycyrrhizin)IBA
11/2017
1AntioxidantsIBA
11/2017
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
11/2017
1Biological ProductsIBA
11/2017
1Antidepressive Agents (Antidepressants)IBA
01/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2016
1CorticosteroneIBA
01/2016
15,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
01/2013
1Sodium Channels (Sodium Channel)IBA
01/2013
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2013
1CholesterolIBA
11/2012
1Glucose (Dextrose)FDA LinkGeneric
11/2012
1AdiponectinIBA
11/2012
1Antipsychotic Agents (Antipsychotics)IBA
11/2012
1lipoprotein cholesterolIBA
11/2012
1LeptinIBA
11/2012
1Olanzapine (Zyprexa)FDA Link
11/2012
1Protein Kinases (Protein Kinase)IBA
02/2009
1Aripiprazole (Abilify)FDA Link
12/2008
1Prochlorperazine (Compazine)FDA LinkGeneric
12/2008
1Dopamine AntagonistsIBA
12/2008
1Morphine (MS Contin)FDA LinkGeneric
01/2008
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2008
1KaolinIBA
08/2007
1Glial Fibrillary Acidic ProteinIBA
03/2007
1propentofyllineIBA
03/2007
1Phosphotransferases (Kinase)IBA
08/2005
1Mutant Proteins (Protein, Mutant)IBA
08/2005
1Pharmaceutical PreparationsIBA
07/2004
1benzocycloheptapyridineIBA
07/2004
1S 312IBA
07/2004
1Dopamine (Intropin)FDA LinkGeneric
08/2003
1Methamphetamine (Desoxyn)FDA LinkGeneric
08/2003
1Glutamic Acid (Glutamate)FDA Link
09/2002
1beta-Galactosidase (Lactaid)IBA
08/2002
1N-acetylaspartate (N-acetyl aspartate)IBA
08/2002
1N-Methylaspartate (NMDA)IBA
02/2002

Therapy/Procedure

1Aftercare (After-Treatment)
01/2017
1Ligation
03/2007
1Oral Administration
07/2004